Xenetic 股價、新聞與催化劑

股票表現

股價為何變動

最新公司動態「Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics」發布後，XBIO 於 2026年9月16日 收於 $2.19，較前一交易日下跌 48.7%。該變動發生在與這則公司動態對應的交易時段。

公司概覽

未來催化劑

近期新聞

1. 01
   2026-09-16 11:00 EST

   Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics

2. 02
   2026-08-07 12:35 EST

   Xenetic Biosciences Reports Second Quarter 2026 Financial Results and Highlights Strengthened Scientific Foundation Supporting Continued Advancement of Proprietary DNase Platform

3. 03
   2026-06-04 12:40 EST

   Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination With Anti-CD19 CAR T Cells in Large B-Cell Lymphoma

4. 04
   2026-06-01 13:02 EST

   Xenetic Biosciences Showcases Compelling ASCO 2026 Data Demonstrating DNase I Significantly Enhances CAR-T Cell Persistence, Tumor Control, and Survival

5. 05
   2026-05-13 12:05 EST

   Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform

相似股票

商業成熟度、治療領域或催化劑模式相近的同業公司。